Investigators from Albany Medical Center Target Viremia (Increased Cmv Disease and "severe" Bk Viremia With Belatacept Vs. Sirolimus Three-drug Maintenance Immunosuppression).
In: Drug Week, 2023-09-29, S. 866-866
serialPeriodical
Zugriff:
Keywords: Albany; State:New York; United States; North and Central America; Drugs and Therapies; Health and Medicine; Immunology; Immunosuppression; Immunosuppressive Agents; Macrolides; Pharmaceuticals; Selective T-Cell Costimulation Blockers; Sirolimus; Sirolimus Therapy; T-Lymphocyte Costimulation Activity Blockade; Viremia; Virology; Virus Diseases and Conditions EN Albany State:New York United States North and Central America Drugs and Therapies Health and Medicine Immunology Immunosuppression Immunosuppressive Agents Macrolides Pharmaceuticals Selective T-Cell Costimulation Blockers Sirolimus Sirolimus Therapy T-Lymphocyte Costimulation Activity Blockade Viremia Virology Virus Diseases and Conditions 866 866 1 09/25/23 20230929 NES 230929 2023 SEP 29 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on Virology - Viremia is the subject of a report. We aim to assess the incidence of CMV and BK viremia in patients treated with sirolimus or belatacept as part of a three-drug immunosuppression regimen after kidney transplantation.". [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Investigators from Albany Medical Center Target Viremia (Increased Cmv Disease and "severe" Bk Viremia With Belatacept Vs. Sirolimus Three-drug Maintenance Immunosuppression).
|
---|---|
Zeitschrift: | Drug Week, 2023-09-29, S. 866-866 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Sonstiges: |
|